Literature DB >> 32369864

An update on genetic variants of the NKX2-5.

Jorge E Kolomenski1,2, Marisol Delea3, Leandro Simonetti4, Mónica C Fabbro5, Lucía D Espeche3, Melisa Taboas3, Alejandro D Nadra1,2, Carlos D Bruque3,6, Liliana Dain2,3,6.   

Abstract

NKX2-5 is a homeodomain transcription factor that plays a crucial role in heart development. It is the first gene where a single genetic variant (GV) was found to be associated with congenital heart diseases in humans. In this study, we carried out a comprehensive survey of NKX2-5 GVs to build a unified, curated, and updated compilation of all available GVs. We retrieved a total of 1,380 unique GVs. From these, 970 had information on their frequency in the general population and 143 have been linked to pathogenic phenotypes in humans. In vitro effect was ascertained for 38 GVs. The homeodomain had the biggest cluster of pathogenic variants in the protein: 49 GVs in 60 residues, 23 in its third α-helix, where 11 missense variants may affect protein-DNA interaction or the hydrophobic core. We also pinpointed the likely location of pathogenic GVs in four linear motifs. These analyses allowed us to assign a putative explanation for the effect of 90 GVs. This study pointed to reliable pathogenicity for GVs in helix 3 of the homeodomain and may broaden the scope of functional and structural studies that can be done to better understand the effect of GVs in NKX2-5 function.
© 2020 Wiley Periodicals LLC.

Entities:  

Keywords:  NKX2-5; associated phenotypes; curated database; genetic variant evaluation; linear motif

Year:  2020        PMID: 32369864     DOI: 10.1002/humu.24030

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  5 in total

1.  A Novel NKX2-5 Variant in a Child with Left Ventricular Noncompaction, Atrial Septal Defect, Atrioventricular Conduction Disorder, and Syncope.

Authors:  Yuya Yamada; Kazushi Yasuda; Yukiko Hata; Naoki Nishida; Keiichi Hirono
Journal:  J Clin Med       Date:  2022-06-02       Impact factor: 4.964

2.  Predicting pathogenicity for novel hearing loss mutations based on genetic and protein structure approaches.

Authors:  Paula I Buonfiglio; Carlos D Bruque; Vanesa Lotersztein; Leonela Luce; Florencia Giliberto; Sebastián Menazzi; Liliana Francipane; Bibiana Paoli; Ernesto Goldschmidt; Ana Belén Elgoyhen; Viviana Dalamón
Journal:  Sci Rep       Date:  2022-01-07       Impact factor: 4.379

3.  A novel KLF13 mutation underlying congenital patent ductus arteriosus and ventricular septal defect, as well as bicuspid aortic valve.

Authors:  Pradhan Abhinav; Gao-Feng Zhang; Cui-Mei Zhao; Ying-Jia Xu; Juan Wang; Yi-Qing Yang
Journal:  Exp Ther Med       Date:  2022-03-01       Impact factor: 2.447

4.  Genetic Analysis in a Familial Case With High Bone Mineral Density Suggests Additive Effects at Two Loci.

Authors:  Núria Martínez-Gil; Diana Ovejero; Natalia Garcia-Giralt; Carlos David Bruque; Leonardo Mellibovsky; Xavier Nogués; Raquel Rabionet; Daniel Grinberg; Susanna Balcells
Journal:  JBMR Plus       Date:  2022-02-18

5.  Case Report: A Novel NKX2-5 Mutation in a Family With Congenital Heart Defects, Left Ventricular Non-compaction, Conduction Disease, and Sudden Cardiac Death.

Authors:  Paula Morlanes-Gracia; Guido Antoniutti; Jorge Alvarez-Rubio; Laura Torres-Juan; Damian Heine-Suñer; Tomás Ripoll-Vera
Journal:  Front Cardiovasc Med       Date:  2021-07-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.